Discontinued — last reported Q3 '25
Insmed Intangibles (Net) decreased by 2.1% to $95.57M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 66.5%, from $57.39M to $95.57M. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows an upward trend with a 14.7% CAGR.
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
intangible_assets_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $46.74M | $75.07M | $73.81M | $72.55M | $71.28M | $70.02M | $68.76M | $67.49M | $66.23M | $64.97M | $63.70M | $62.44M | $61.18M | $59.92M | $58.65M | $57.39M | $56.13M | $84.59M | $97.65M | $95.57M |
| QoQ Change | — | +60.6% | -1.7% | -1.7% | -1.7% | -1.8% | -1.8% | -1.8% | -1.9% | -1.9% | -1.9% | -2.0% | -2.0% | -2.1% | -2.1% | -2.2% | -2.2% | +50.7% | +15.4% | -2.1% |
| YoY Change | — | — | — | — | +52.5% | -6.7% | -6.8% | -7.0% | -7.1% | -7.2% | -7.3% | -7.5% | -7.6% | -7.8% | -7.9% | -8.1% | -8.3% | +41.2% | +66.5% | +66.5% |